MSD Growth Fund Holds 5.15% Of ODDITY Tech's Class A Shares

MSD Partners and BDT & MSD chairman and co-CEO Byron D. Trott report beneficial ownership of the fund's same position.

Share
MSD Growth Fund Holds 5.15% Of ODDITY Tech's Class A Shares

MSD Growth Fund held 5.15% of ODDITY Tech's Class A shares as of June 30, 2026, according to an SEC ownership disclosure filed Wednesday. ODDITY sells beauty and wellness products online using its own technology to match shoppers to products.

One Fund Holding, Shared Authority

The position consists of 1,781,661 Class A ordinary shares owned directly by MSD Growth Fund. MSD Partners, the fund's investment adviser, reports beneficial ownership of those securities, a measure that includes authority over shares held by another entity.

Byron D. Trott, chairman and co-CEO of BDT & MSD, also reports beneficial ownership because he exercises investment discretion over the fund's ODDITY holdings. MSD Partners is wholly owned by BDT & MSD.

The fund, adviser and Trott each reported shared authority to vote and sell the shares. Each listed zero shares under sole voting or selling authority. Their ownership entries refer to the same fund position.

The percentage uses ODDITY's reported 34,577,554 Class A shares outstanding on June 12, 2026. ODDITY reported that count in a June 16, 2026, SEC filing. The 5.15% figure applies specifically to Class A shares.

Beauty, Wellness And Dermatology Online

ODDITY's business spans IL MAKIAGE, its beauty brand; SpoiledChild, which sells skincare, haircare and supplements; and METHODIQ, a medical telehealth platform starting with dermatology.

Its platform uses algorithms, machine learning and computer vision to match customers with products. Items generally cost between $20.00 and $100.00, and third-party manufacturing partners make them.

The platform had served approximately 68 million users as of December 31, 2025, according to ODDITY's annual report. Revenue for 2025 was $810 million, approximately 18% of it from sales outside the United States.

ODDITY has offices in Tel Aviv and New York City, plus a biotechnology laboratory in Boston.

The ownership disclosure classifies the fund's position as passive: the shares are not held for the purpose of changing or influencing ODDITY's control.

Sources

More on ODDITY Tech

All ODDITY Tech (ODD) coverage →